Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD007 in Adult Subjects With Asthma
NCT02615080Phase 2Completed
- Sponsor
- RSPR Pharma
- Start
- Nov 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pemirolast in asthma, sponsored by RSPR Pharma. Started Nov 2015; status: completed.
02
Drugs
pemirolast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02615080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615080.